FDA approves 1st rapid-acting insulin
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by a near-total absence of ...
A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback